CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells. - Naito M; Hainz U; Burkhardt UE; Fu B; Ahove D; Stevenson KE; Rajasagi M; Zhu B; Alonso A; Witten E; Matsuoka K; Neuberg D; et al. (Cancer immunology, immunotherapy : CII, 2013)